Enhanced LH action in transgenic female mice expressing hCGβ-subunit induces pituitary prolactinomas; the role of high progesterone levels
Open Access
- 1 September 2010
- journal article
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 17 (3) , 611-621
Abstract
The etiology of pituitary adenomas remains largely unknown, with the exception of involvement of estrogens in the formation of prolactinomas. We have examined the molecular pathogenesis of prolactin-producing pituitary adenomas in transgenic female mice expressing the human choriongonadotropin (hCG) β-subunit. The LH/CG bioactivity is elevated in the mice, with consequent highly stimulated ovarian progesterone (P4) production, in the face of normal estrogen secretion. Curiously, despite normal estrogen levels, large prolactinomas developed in these mice, and we provide here several lines of evidence that the elevated P4 levels are involved in the growth of these estrogen-dependent tumors. The antiprogestin mifepristone inhibited tumor growth, and combined postgonadectomy estradiol/P4 treatment was more effective than estrogen alone in inducing tumor growth. Evidence for direct growth-promoting effect of P4 was obtained from cultures of primary mouse pituitary cells and rat somatomammotroph GH3 cells. The mouse tumors and cultured cells revealed stimulation of the cyclin D1/cyclin-dependent kinase 4/retinoblastoma protein/transcription factor E2F1 pathway in the growth response to P4. If extrapolated to humans, and given the importance of endogenous P4 and synthetic progestins in female reproductive functions and their pharmacotherapy, it is relevant to revisit the potential role of these hormones in the origin and growth of prolactinomas.Keywords
This publication has 42 references indexed in Scilit:
- Effects of estradiol and medroxyprogesterone acetate on expression of the cell cycle proteins cyclin D1, p21 and p27 in cultured human breast tissuesCell Cycle, 2008
- High Prevalence of Pituitary Adenomas: A Cross-Sectional Study in the Province of Liège, BelgiumThe Journal of Clinical Endocrinology & Metabolism, 2006
- HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activityCancer Cell, 2006
- Fetal but not adult Leydig cells are susceptible to adenoma formation in response to persistently high hCG level: a study on hCG overexpressing transgenic miceOncogene, 2005
- Estrogens and Progesterone Promote Persistent CCND1 Gene Activation during G 1 by Inducing Transcriptional Derepression via c- Jun /c- Fos /Estrogen Receptor (Progesterone Receptor) Complex Assembly to a Distal Regulatory Element and Recruitment of Cyclin D1 to Its Own Gene PromoterMolecular and Cellular Biology, 2004
- Pituitary Tumor Registry: A Novel Clinical Resource1The Journal of Clinical Endocrinology & Metabolism, 2000
- CDK inhibitors p18INK4c and p27Kip1 mediate two separate pathways to collaboratively suppress pituitary tumorigenesisGenes & Development, 1998
- Epidemiology and pathogenesis of pituitary adenomas.1993
- Effect of short-term starvation on reproductive hormone gene expression, secretion and receptor levels in male ratsJournal of Endocrinology, 1989
- Effects of Estrogen and Progesterone on Serum and Pituitary Prolactin Levels in Ovariectomized RatsEndocrinology, 1970